MARK TO MARKET 4,247.49 01 10/27 WIRED FUNDS RECEIVED BY WIRE 29,704.00 03 10/27 MRKD/MARKET MARK TO MARKET 4,247.49 03 10/27 SOLD -2,000 AMYLIN PHARMACEUTICALS INC 36.00000 71,987.49 DONE AT EDGETRADE.COM INC. 01 10/28 JOURNAL S/D FINANCING RETURN 236,825.51 FROM 746FY0 TO 2F8EE0 01 10/28 JOURNAL S/0 F

199.50 DONE AT EDGETRADE.COM INC. 03 02/27 SOLD -4,000 DUKE ENERGY CORP 28.69750 114,764.47 DONE AT EDGETRADE.COM INC. 03 02/27 SOLD -1,000 AMYLIN PHARMACEUTICALS INC 40.63000 40,624.02 DONE AT EDGETRADE.COM INC. 01 02/28 JOURNAL 5/0 FINANCING RETURN 14,160.26 FROM 746FY0 TO 2F8EE0 01 02/28 JOURNAL S/D FI

SSE INV REP ACCOUNT TAXPAYER ID. STATEMENT PERIOD PAGE UNDISCLOSED 03/01/06 TO 03/31/06 8 OF 14 TRADING ACTIVITY FOR THE MONTH DESCRIPTION AMYLIN PHARMACEUTICALS INC SR 02.5000 04/15/2011 DONE AT DEUTSCHE BNK/ALEX BROWN FUNDS RECEIVED BY WIRE HIGUBRIDGE CAPITAL MANA S/D FINANCING RETURN FROM TO S/D FINAN

,259,320.83 FROM 2F8EE0 TO 746FY0 01 03/06 WIRED FUNDS RECEIVED BY WIRE 17,361.00 746FY0 HIGHBRIDGE CAPITAL MANA 01 03/06 JOURNAL 1,000,000 AMYLIN PHARMACEUTICALS INC SR 1,403,581.67 02.5000 04/15/2011 TO 736FY0 FROM 7461'10 03 03/06 JOURNAL -25,400 AMYLIN PHARMACEUTICALS INC 1,115,060.00 OFFSHORE ARRANGIN

HIO SR 45.70680 914,136.00 01 2,000,000 NT CV1. 01.4861 06/02/2033 AMGEN INC NT ZER CV 32 79.00000 1,580,000.00 01 1,000,000 03/01/2032 AMYLIN PHARMACEUTICALS INC SR 123.37500 1,233,750.00 01 17,000 NT CV 2 02.5000 04/15/2011 BARNES GROUP INC CVT 144A 102.87500 17,488.75 01 3,000,000 03.7500 08/01/

880,000.00 29,720.00 3.377 NT CV1. 01.4861 06/02/2033 01 2,000,000 AMGEN INC NT ZER CV 32 78.00000 1,560,000.00 03/01/2032 01 1,000,000 AMYLIN PHARMACEUTICALS INC SR 127.12500 1,271,250.00 25,000.00 1.967 NT CV 2 02.5000 04/15/2011 01 17,000 BARNES GROUP INC CVT 144A 99.00000 16,830.00 637.50 3.78

s 03 9,955 (S) AMGEN 78.86000 7e5,051.30- •CSFB RATING :NEUTRAL INDEPENDENT RATING:5 STAR - Buy PROVIDER:Standard & Poor's 03 22,400 (S) AMYLIN PHARMACEUTICALS INC 39.92000 894,208.00- 03 253 (S) BARNES GROUP INC 33.00000 8,349.00- 222.64- 2.667 03 12,523 (S) CBRL GROUP INC 35.15000 440,183.45- 6,5

3480 SHARES 03 10/14/05 SUBST CHGD FRANKLIN RESOURCES INC 2,610.00 SUBSTITUTE DIVIDEND CHARGE 10/14/05 ON -26100 SHARES 01 10/17/05 INTEREST AMYLIN PHARMACEUTICALS INC SR 12,500.00 02.5000 04/15/2011 INTEREST CREDIT 10/15/05 ON 1000000 BONDS 01 10/17/05 INTEREST WALT DISNEY COMPANY CVT 10,625.00 02.1250 04/1

CREDIT 01 10/28 WIRED FUNDS PAID BY WIRE 8,940.00 WIRE TO CITIBANK 03 10/28 MRKD/MARKET MARK TO MARKET 467,667.56 03 10/28 JOURNAL -2,000 AMYLIN PHARMACEUTICALS INC 71,987.49 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 01 10/31 MRKD/MARKET MARK TO MARKET 380,869.58 03 10/31 MRKD/MARKET MARK TO MARKET

s 03 6,070 IS) AMGEN 75.62000 459,013.40- *CSFB RATING :NEUTRAL INDEPENDENT RATING:5 STAR - Buy PROVIDER:Standard 6 Poor's 03 22,400 IS) AMYLIN PHARMACEUTICALS INC 33.55000 751,520.00- 03 253 (S) BARNES GROUP INC 35.00000 8,855.00- 222.64- 2.514 03 12,523 IS) CBRL GROUP INC 34.69000 434,422.87- 6

INC SR NT CV ZERO 22 101.25000 3,408,075.00 11/06/2022 01 2,000,000 AMGEN INC NT ZER CV 32 77.24305 1,544,861.00 03/OL/2032 01 1,000,000 AMYLIN PHARMACEUTICALS INC SR 113.25750 1,132,575.00 25,000.00 2.207 NT CV 2 02.5000 04/15/2011 01 17,000 BARNES GROUP INC CVT 144A 83.62000 14,215.40 637.50 4.48

HIO SR 99.21200 984,290.00 NT CVI. 01.4861 06/02/2033 01 2,000,000 AMGEN INC NT ZER CV 32 76.25000 1,525,000.00 03/01/2032 01 1,000,000 AMYLIN PHARMACEUTICALS INC SR 137.81800 1,378,180.00 NT CV 2 02.5000 04/15/2011 01 17,000 BARNES GROUP INC CVT 144A 106.50000 18,105.00 03.7500 08/01/2025 01 17,00

s 03 5,660 IS) AMGEN 75.48000 427,216.80- 'CSSU RATING :Restricted INDEPENDENT RATING:Not Shown PROVIDER:Standard 6 Poor's 03 25,400 4S) AMYLIN PHARMACEUTICALS INC 43.38000 1,101,852.00- 03 19,223 IS) CBRL GROUP INC 44.43000 854,077.89- 'CSSU RATING :NOT RATED INDEPENDENT RATING:2 STAR - Avoid PROVIDE

1/17 MRKD/MARKET MARK TO MARKET 300,141.64 03 01/17 JOURNAL 2,646 INTERNATIONAL GAME TECHNOLOGIES CLOSE SHORT VS BOX 03 01/17 JOURNAL -2,000 AMYLIN PHARMACEUTICALS INC 86,947.83 OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 03 01/17 JOURNAL 3,010 DUKE ENERGY CORP CLOSE SHORT VS BOX 03 01/17 JOURNAL -650 AMER

GROUP INC OHIO SR 45.37500 907,500.00 29,720.00 3.275 NT CV1. 01.4861 06/02/2033 AMGEN INC NT ZER CV 32 75.91577 1,518,315.40 03/01/2032 AMYLIN PHARMACEUTICALS INC SR 135.79940 1,357,994.00 25,000.00 1.841 NT CV 2 02.5000 04/15/2011 BARNES GROUP INC CVT 144A 106.00000 18,020.00 637.50 3.538 03.7500

MARKET 24,850.56 03 03/03 MRKD/MARKET MARK TO MARKET 24,850.56 01 03/06 MRKD/MARKET MARK TO MARKET 165,243.33 01 03/06 JOURNAL -1,000,000 AMYLIN PHARMACEUTICALS INC SR 1,403,581.67 02.5000 04/15/2011 TO 736FY0 FROM 746FY0 03 03/06 MRKD/MARKET MARK TO MARKET 165,243.33 03 03/06 JOURNAL 25,400 AMYLIN PHAR

RRANGING FLIP TO 736FY0 FROM 746FY0 -900 VORNADO REALTY TR DONE AT EDGETRADE.COM INC. -4,000 DUKE ENERGY CORP DONE AT EDGETRADE.COM INC. -1,000 AMYLIN PHARMACEUTICALS INC DONE AT EDGETRADE.COM INC. S/D FINANCING RETURN FROM 746FY0 TO 2F8EE0 S/D FINANCING FROM 2F8EE0 TO 746FY0 FUNDS RECEIVED BY WIRE 746FY0 HIGHBRID

RMACEUTICALS INC OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 650 AMERICAN FINL GROUP INC OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 -2,000 AMYLIN PHARMACEUTICALS INC DONE AT EDGETRADE.COM INC. -650 AMERICAN FINL GROUP INC DONE AT EDGETRADE.COM INC. S/D FINANCING RETURN FROM 746FY0 TO 2F8EE0 S/D FINANCING FROM

S/D FINANCING RETURN FROM 746FY0 TO 2F8EE0 S/D FINANCING FROM 2F8EE0 TO 746FY0 FUNDS RECEIVED BY WIRE 746FY0 HIGHBRIDGE CAPITAL MANA 1,000,000 AMYLIN PHARMACEUTICALS INC 02.5000 04/15/2011 TO 736FY0 FROM 746FY0 EFTA01593392 -25,400 AMYLIN PHARMACEUTICALS INC OFFSHORE ARRANGING FLIP TO 736FY0 FROM 746FY0 25,400